TITLE

Emergent BioSolutions Lands $1.25B BioThrax Contract

AUTHOR(S)
Powers, Marie
PUB. DATE
October 2011
SOURCE
BioWorld Today;10/4/2011, Vol. 22 Issue 192, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that U.S. Centers for Disease Control and Prevention has awarded Emergent BioSolutions Inc. worth 1.25 U.S. billion dollars to supply the U.S. government with 44.75 million doses of anthrax vaccine adsorbed, BioThrax for about five years. BioThrax is the only anthrax vaccine that is approved by the Food and Drug Administration (FDA). Deliveries of the BioThrax will start 2011 and will end in September 2016.
ACCESSION #
66423965

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics